To provide for the conduct of a study to identify underlying contributing factors for pediatric cancer that are unique to certain States and to provide assistance to support States with a high incidence of such cancer.
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Senate amendment proposed (on the floor): Amendment SA 3650 proposed by Senator Moran for Senator Shaheen to Amendment SA 3399.(consideration: CR S5499-5503; text: CR S5501-5502)
July 31, 2018
View full timeline
Senate amendment proposed (on the floor): Amendment SA 3650 proposed by Senator Moran for Senator Shaheen to Amendment SA 3399.(consideration: CR S5499-5503; text: CR S5501-5502)
July 31, 2018
Senate amendment agreed to: Amendment SA 3650 agreed to in Senate by Voice Vote.
July 31, 2018
Amendment SA 3650 proposed by Senator Moran for Senator Shaheen to Amendment SA 3399. (consideration: CR S5499-5503; text: CR S5501-5502) To provide for the conduct of a study to identify underlying contributing factors for pediatric cancer that are unique to certain States and to provide assistance to support States with a high incidence of such cancer.
July 31, 2018
Amendment SA 3650 agreed to in Senate by Voice Vote.
July 31, 2018
Senate amendment submitted
July 26, 2018
Text
Submitted
SA 3650. Mrs. SHAHEEN (for herself, Ms. Collins, Mr. Murphy, Mr. Blumenthal, Mrs. Gillibrand, Mr. Menendez, Mr. Merkley, Mr. Booker, Ms. Hassan, and Mr. King) submitted an amendment intended to be proposed to amendment SA 3399 proposed by Mr. Shelby to the bill H.R. 6147, making appropriations for the Department of the Interior, environment, and related agencies for the fiscal year ending September 30, 2019, and for other purposes; which was ordered to lie on the table; as follows: At the appropriate place in Division A, insert the following: SEC. __. ADDRESSING PEDIATRIC CANCER RATES IN THE UNITED STATES. (a) Report Identifying Geographic Variation of Types of Pediatric Cancer.--Using funds appropriated under the heading ``Toxic Substances and Environmental Health'' for the Agency for Toxic Substances and Disease Registry, the Secretary of Health and Human Services, not later than 180 days after the date of enactment of this Act, shall submit to the Committee on Health, Education, Labor, and Pensions of the Senate, the Committee on Appropriations of the Senate, the Committee on Energy and Commerce of the House of Representatives, and the Committee on Appropriations of the House of Representatives, a report that provides details on the geographic variation in pediatric cancer incidence in the United States, including-- (1) the types of pediatric cancer within each of the 10 States with the highest age-adjusted incidence rate of cancer among persons aged 20 years or younger; (2) geographic concentrations of types and prevalence of pediatric cancers within each such State, in accordance with Centers for Disease Control and Prevention guidelines; and (3) an update on current activities related to pediatric cancer, including with respect to carrying out section 399V-6 of the Public Health Service Act (42 U.S.C. 280g-17). (b) Support for States With High Incidence of Pediatric Cancer.--Using funds appropriated under the heading ``Toxic Substances and Environmental Public Health'' for the Agency for Toxic Substances and Disease Registry, the Secretary of Health and Human Services may conduct public outreach, in collaboration with State departments of health, particularly in the 10 States with the highest age-adjusted incidence rate of cancer among persons aged 20 years or younger, to improve awareness by residents, clinicians, and others, as appropriate, of possible contributing factors to pediatric cancer, including environmental exposures, in a manner that is complementary of, and does not conflict with, ongoing pediatric cancer-related activities supported by the Department of Health and Human Services. (c) Privacy.--The Secretary of Health and Human Services shall ensure that all information with respect to patients that is contained in the reports under this section is de- identified and protects personal privacy of such patients in accordance with applicable Federal and State privacy law. ______